Progression of endometriosis to cancer: Too MUCh FoxP3+ regulatory T-cell response?

DMM Disease Models and Mechanisms

Volumn 4, Issue 2, 2011, Pages 139-140

  Prieto, G Aleph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUCIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RECOMBINANT ENZYME; TRANSCRIPTION FACTOR FOXP3; TUMOR ANTIGEN; TUMOR MARKER;

ANTIBODY TITER; CANCER GROWTH; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM CANCER; EPIGENETICS; ESTROGEN ACTIVITY; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC MANIPULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LESIONS AND DEFECTS; LOSS OF FUNCTION MUTATION; MALIGNANT TRANSFORMATION; NONHUMAN; NOTE; OVARIAN ENDOMETRIOTIC CYST; OVARIAN LESION; OVARY; OVARY CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; MICE, TRANSGENIC; MUCIN-1; T-LYMPHOCYTES, REGULATORY;

EID: 79952339753     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.007278     Document Type: Note

References (14)

1. Bafna, S., Kaur, S. and Batra, S. K. (2010). Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 29, 2893-2904.
2. + regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum. Reprod. 25, 900-907.
3. + regulatory T cells. Dis. Model. Mech. 2, 593-603.
4. Cao, X. (2010). Regulatory T cells and immune tolerance to tumors. Immunol. Res. 46, 79-93.
5. Dinulescu, D. M., Ince, T. A., Bradley, J. Q., Shafer, S. A., Crowley, D. and Jacks, T. (2005). Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med. 11, 63-70. (Pubitemid 40215839)
6. Giudice, L. C. (2010). Endometriosis. N. Engl. J. Med. 362, 2389-2398.
7. Mandai, M., Yamaguchi, K., Matsumura, N., Baba, T. and Konishi, I. (2009). Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int. J. Clin. Oncol 14, 383-391.
8. + regulatory T cells by promoting their proliferation. Immunology 118, 58-65.
9. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. (1995). Immunological self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
10. + regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490-500.
11. Tirado-Gonzalez, I., Barrientos, G., Tariverdian, N., Arck, P. C., Garcia, M., Klapp, B. F. and Blois, S. M. (2010). Endometriosis research: animal models for the study of complex disease. J. Reprod. Immunol. 86, 141-147.
12. Van Elssen, C. H. M. J., Frings, P. W. H., Bot, F. J., Van de Vijver, K. K., Huls, M. B., Meek, B., Hupperets, P., Germeraad, W. T. V. and Bos, G. M. J. (2010). Expression of aberrantly glycosylated Mucin-1 in ovarian cancer. Histopathology 57, 597-606.
13. + Treg: divide and rule? Immunology 111,129-137.
14. Willimsky, G., Czeh, M., Loddenkemper, C., Gellermann, J., Schmidt, K., Wust, P., Stein, H. and Blankenstein, T. (2008). Immunogenicity of premalignant lesions is the primary cause of general cytotoxicity T lymphocyte unresponsiveness. J. Exp. Med. 205, 1687-1700. (Pubitemid 351962031)